CN105218585A - A kind of preparation method of genistein chromic compound - Google Patents
A kind of preparation method of genistein chromic compound Download PDFInfo
- Publication number
- CN105218585A CN105218585A CN201510601671.8A CN201510601671A CN105218585A CN 105218585 A CN105218585 A CN 105218585A CN 201510601671 A CN201510601671 A CN 201510601671A CN 105218585 A CN105218585 A CN 105218585A
- Authority
- CN
- China
- Prior art keywords
- genistein
- preparation
- chromic compound
- reaction
- precipitate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The preparation method of a kind of genistein chromic compound of the present invention, adds concentration 60% ethanol in genistein; Heated and stirred adds CrCl again
36H
2o; Dropwise add sodium hydroxide adjust ph to 7 ~ 9 again, solution transition is blackish green suspending system; Suction filtration will be precipitated; With deionized water and dehydrated alcohol respectively by after washing of precipitate for several times, collecting precipitation, vacuum-drying, to obtain final product.The invention provides a kind of new genistein chromic compound preparation method, under the condition not adding catalyzer, first genistein is alkalized into sodium salt, then genistein sodium salt and chromium chloride are carried out ligand substituting, thus obtain its metal complexes, the temperature of reaction of genistein sodium salt and chromium chloride controls at 60 ~ 70 DEG C, and the reaction times is 3 ~ 4 hours, and productive rate is 60%.Compared with bibliographical information, reduce temperature of reaction, also substantially reduce the reaction times, significantly improve products collection efficiency.
Description
Technical field
The present invention relates to a kind of preparation method of genistein chromic compound, further there is provided a kind of new preparation method, there is shortening preparation time, and improve the features such as productive rate, belong to compou nd synthesis technical field.
Background technology
Genistein (Genistein) is that one has multiple bioactive flavonoid compound, chemical name is Genistein, extensively be present in traditional medicinal plant such as soybean and trifolium, Flower of Chinese Peashrub, Chinese honey locust, the Fructus Sophorae, there is very high pharmaceutical use.
The molecular formula of genistein chromic compound: [C
15h
9o
5]
3cr2H
2o; Molecular weight: 895.5; Called after: genistein chromic compound; Structural formula is:
The preparation method of existing genistein chromic compound is the method adopting genistein and chromium acetate direct reaction, and shortcoming is that the time is longer, reaction needed 18 hours, and needs the ageing of 48 hours, and productive rate is lower.
Summary of the invention
The object of the present invention is to provide a kind of preparation method of genistein chromic compound, be that existing lignin chromic compound preparation method is improved, improve productive rate, shorten preparation time.
The preparation method of a kind of genistein chromic compound of the present invention, comprises the following steps:
1, in genistein in quality: volume is that the ratio of 1:37 ~ 50 adds concentration 60% ethanol;
2, be heated to 60 ~ 70 DEG C stir 0.5 ~ 1.0 hour, then add CrCl
36H
2o, adding proportion is for being 1:1 ~ 1:2 with genistein mol ratio;
3, dropwise add sodium hydroxide adjust ph to 7 ~ 9 of 2mol/L again, solution transition is blackish green suspending system;
4, there is a large amount of grass green to precipitate after 3 ~ 4h to generate, will suction filtration be precipitated;
5, use deionized water and dehydrated alcohol respectively by after washing of precipitate for several times, collecting precipitation, vacuum-drying, obtains graminaceous pulverulent solids.
positively effect of the present invention is:provide a kind of new genistein chromic compound preparation method, under the condition not adding catalyzer, first genistein is alkalized into sodium salt, then genistein sodium salt and chromium chloride are carried out ligand substituting, thus obtain its metal complexes, the temperature of reaction of genistein sodium salt and chromium chloride controls at 60 ~ 70 DEG C, and the reaction times is 3 ~ 4 hours, and productive rate is 60%.Compared with bibliographical information, reduce temperature of reaction, also substantially reduce the reaction times, significantly improve products collection efficiency.
Accompanying drawing explanation
Fig. 1 is the ultraviolet spectrogram of embodiment 1;
Fig. 2 is the infrared spectrogram of embodiment 1;
Fig. 3 is the TG-DTA spectrogram of embodiment 1;
Fig. 4 is the ultraviolet spectrogram of embodiment 2;
Fig. 5 is the infrared spectrogram of embodiment 2;
Fig. 6 is the TG-DTA spectrogram of embodiment 2;
Fig. 7 is the ultraviolet spectrogram of embodiment 3;
Fig. 8 is the infrared spectrogram of embodiment 3;
Fig. 9 is the TG-DTA spectrogram of embodiment 3.
Embodiment
Below by way of specific embodiment, the present invention is further described, but these embodiments are not limited to protection scope of the present invention.
embodiment 1
Take genistein 1.35g(5mmol) in 100mL there-necked flask, add the ethanol of 50mL60%, 65 DEG C of heated and stirred 0.5 hour, add 1.23g(5mmol afterwards) CrCl
36H
2o, dropwise adding the sodium hydroxide adjust ph to 7.5 of 2mol/L, solution transition is blackish green suspending system, has a large amount of grass green to precipitate and generate after 3.5h.To precipitate suction filtration, with deionized water and dehydrated alcohol respectively by after washing of precipitate for several times, collecting precipitation, vacuum-drying, obtains graminaceous pulverulent solids, and productive rate is 60%.Before improving far above existing synthetic method 41%, and the reaction times greatly shorten, by 18 ~ 20h(before improving and need the ageing of 48h) taper to current 3.5h.
embodiment 2
Take genistein 1.35g(5mmol) in 100mL there-necked flask, add the ethanol of 60mL60%, 67 DEG C of heated and stirred 0.5 hour, add 1.23g(5mmol afterwards) CrCl
36H
2o, dropwise adding the sodium hydroxide adjust ph to 8 of 2mol/L, solution transition is blackish green suspending system, has a large amount of grass green to precipitate and generate after 3h.To precipitate suction filtration, with deionized water and dehydrated alcohol respectively by after washing of precipitate for several times, collecting precipitation, vacuum-drying, obtains graminaceous pulverulent solids, and productive rate is 60%.Before improving far above existing synthetic method 41%, and the reaction times greatly shorten, by 18 ~ 20h(before improving and need the ageing of 48h) taper to current 3h.
embodiment 3
Take genistein 1.35g (5mmol) in 100mL there-necked flask, add the ethanol of 55mL60%, 70 DEG C of heated and stirred 0.5 hour, add 1.23g (5mmol) CrCl afterwards
36H
2o, dropwise adding the sodium hydroxide adjust ph to 9 of 2mol/L, solution transition is blackish green suspending system, has a large amount of grass green to precipitate and generate after 4h.To precipitate suction filtration, with deionized water and dehydrated alcohol respectively by after washing of precipitate for several times, collecting precipitation, vacuum-drying, obtains graminaceous pulverulent solids, and productive rate is 60%.Before improving far above existing synthetic method 41%, and the reaction times greatly shorten, by 18 ~ 20h(before improving and need the ageing of 48h) taper to current 4h.
genistein chromic compound test example to prepared by the embodiment of the present invention 1 ~ embodiment 3:
1. title complex physico-chemical property and ultimate analysis
Genistein chromic compound is grass green pulverulent solids, can be dissolved in dimethyl sulfoxide (DMSO) (DMSO), DMF, be slightly soluble in methyl alcohol, acetone, be insoluble in water, CCl4.With VarioEL type elemental analyser, C, the H in genistein chromic compound is measured, the content EDTA method titration of chromium.Mass spectroscopy (electrospray ionization source ESI) is carried out with ThermoLQTOrbitrapXL LC-MS instrument.
The ultimate analysis of table 1 title complex of the present invention
2. differential thermal and thermogravimetric analysis
Under fluidizing air, heat-up rate 10 DEG C/min, measures the thermography of title complex.Can find out that chromium is combined with two zero-g periods from TG-DTA spectrogram.The weightlessness of title complex first stage is at about 75 DEG C, and rate of weight loss is 3.94%, and with the amount suitable (theoretical rate of weight loss is 4.02%) losing 2 water moleculess, corresponding have very little absorption peak on DTA curve, illustrates that title complex has the crystal water of 2 molecules.Second stage is from 320 DEG C to 420 DEG C, rate of weight loss is 86.99%, with lose 3 ligand moleculars quite (theoretical rate of weight loss is 87.5%), correspondence shows as a very large exothermic peak on DTA curve, for the oxygenolysis peak of title complex, wherein about 400 DEG C very exothermic, show that 3 molecule ligands decompose rapidly, chromium is then oxidized in atmosphere.The resistates that title complex obtains after decomposing is the oxide compound Cr of chromium
2o
3, (embodiment 1-3 prepares sample TG-DTA spectrogram and sees accompanying drawing).
3. Infrared spectroscopy
At 400-4000cm
-1in scope, measure the infrared spectrogram of ligands and complexes with Thermo-NicoletNexus type Fourier transformation infrared spectrometer (KBr compressing tablet).Dominant spectral data list in table 2.
The major infrared spectrum modal data of table 2 genistein and chromic compound and ownership (cm thereof
-1)
Compound | V(O-H) | V(C=O) | V(C=C) | V(C-O-C) | V(O-M) |
Genistein(L) | 3412 | 1652 | 1616 | 1259 | |
CrL 3·2H 2O | 3438 | 1629 | 1612 | 1263 | 498 |
The infrared spectra of part and chromic compound is compared: 4 carbonylic stretching vibration frequency v (C=O) of genistein are positioned at 1652cm from table 2 data
-1, after forming title complex, move to 1629cm
-1, the 23cm to the displacement of lower wave number direction
-1, as can be seen here, 4 ketonic oxygens of part participate in coordination.The stretching vibration v(C=C of 5-OH place phenyl ring skeleton) obviously weaken in title complex, wave number also has minimizing; The 3412cm of genistein
-1stretching vibration frequency wave number after formation title complex of left and right hydroxyl adds 26cm
-1, this is all that 5-OH participation coordination causes.In part, the stretching vibration v (C-O-C) of aryl oxide key is with to form change in location after title complex little, illustrates that the oxygen on genistein aryl oxide key does not participate in coordination (embodiment 1-3 prepares sample infrared spectrogram and sees accompanying drawing).
4. the UV spectrum of title complex
At DMSO:CH
3in OH=1:9 solvent there are two feature ultraviolet absorption peaks at 260nm and 330nm in genistein.Form latter two peak band of title complex all to move to long wave direction, it is weak that maximum absorption wavelength is respectively 269nm and 393nm().Wherein, strong absorption band II by after 260nm red shift 9nm to 269nm, and weak absorbing band I also has larger displacement, its reason be in genistein molecule B ring can not with the unsaturated carbonyl conjugation of C ring, make its with I absorption intensity weaken, be an acromion; And because 3 genistein molecules are by 4 carbonyls and 5 hydroxyls and chromium coordination in title complex, the flush type of whole molecule being strengthened, conjugated system increases, and causes band I red shift, intensity summary increasing.Ultraviolet data also demonstrate 4 carbonyls of genistein and 5 hydroxyls take part in coordination (embodiment 1-3 prepares sample ultraviolet spectrogram and sees accompanying drawing).
Claims (1)
1. a preparation method for genistein chromic compound, comprises the following steps:
1) in genistein in quality: volume is that the ratio of 1:37 ~ 50 adds concentration 60% ethanol;
2) be heated to 60 ~ 70 DEG C stir 0.5 ~ 1.0 hour, then add CrCl
36H
2o, adding proportion is for being 1:1 ~ 1:2 with genistein mol ratio;
3) dropwise add sodium hydroxide adjust ph to 7 ~ 9 of 2mol/L again, solution transition is blackish green suspending system;
4) there is a large amount of grass green to precipitate after 3 ~ 4h to generate, will suction filtration be precipitated;
5) use deionized water and dehydrated alcohol respectively by after washing of precipitate for several times, collecting precipitation, vacuum-drying, obtains graminaceous pulverulent solids.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510601671.8A CN105218585A (en) | 2015-09-21 | 2015-09-21 | A kind of preparation method of genistein chromic compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510601671.8A CN105218585A (en) | 2015-09-21 | 2015-09-21 | A kind of preparation method of genistein chromic compound |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105218585A true CN105218585A (en) | 2016-01-06 |
Family
ID=54987915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510601671.8A Pending CN105218585A (en) | 2015-09-21 | 2015-09-21 | A kind of preparation method of genistein chromic compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105218585A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106187973A (en) * | 2016-07-15 | 2016-12-07 | 北京中医药大学 | The compositions of a kind of many isoflavone derivatives and preparation method and medical application |
CN110305165A (en) * | 2019-08-22 | 2019-10-08 | 福建农林大学 | A kind of guanidine radicals luteolin-chromium (III) complex compound and preparation method thereof |
CN110437284A (en) * | 2019-08-22 | 2019-11-12 | 福建农林大学 | A kind of 5', 8- bis- (dimethylbiguanide base) luteolin-chromium (III) complex compound |
CN110684004A (en) * | 2018-10-24 | 2020-01-14 | 荆门医药工业技术研究院 | Genistein palladium chelate as well as preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1817896A (en) * | 2006-03-10 | 2006-08-16 | 中山大学 | Compounds like quercetol and metal complex of their glycosides and uses |
CN101857583A (en) * | 2009-04-08 | 2010-10-13 | 温州医学院 | Method for preparing isoflavone metal complexes and anti-tumor medical application |
-
2015
- 2015-09-21 CN CN201510601671.8A patent/CN105218585A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1817896A (en) * | 2006-03-10 | 2006-08-16 | 中山大学 | Compounds like quercetol and metal complex of their glycosides and uses |
CN101857583A (en) * | 2009-04-08 | 2010-10-13 | 温州医学院 | Method for preparing isoflavone metal complexes and anti-tumor medical application |
Non-Patent Citations (3)
Title |
---|
ELZBIETA WOZNICKA等,: "New complexes of La(III), Ce(III), Pr(III), Nd(III), Sm(III), Eu(III)and Gd(III) ions with morin", 《JOURNAL OF INORGANIC BIOCHEMISTRY》 * |
李华,: "染料木素铬(III)配合物的合成、表征及生物活性研究", 《南昌大学硕士研究生学位论文》 * |
楚婧,: "木犀草素与锌、铬衍生物的合成、表征及活性研究", 《佳木斯大学硕士学位论文》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106187973A (en) * | 2016-07-15 | 2016-12-07 | 北京中医药大学 | The compositions of a kind of many isoflavone derivatives and preparation method and medical application |
CN110684004A (en) * | 2018-10-24 | 2020-01-14 | 荆门医药工业技术研究院 | Genistein palladium chelate as well as preparation method and application thereof |
CN110305165A (en) * | 2019-08-22 | 2019-10-08 | 福建农林大学 | A kind of guanidine radicals luteolin-chromium (III) complex compound and preparation method thereof |
CN110437284A (en) * | 2019-08-22 | 2019-11-12 | 福建农林大学 | A kind of 5', 8- bis- (dimethylbiguanide base) luteolin-chromium (III) complex compound |
CN110305165B (en) * | 2019-08-22 | 2022-01-11 | 福建农林大学 | Guanidino luteolin-chromium (III) complex and preparation method thereof |
CN110437284B (en) * | 2019-08-22 | 2022-01-11 | 福建农林大学 | 5', 8-di (dimethyldiguanidino) luteolin-chromium (III) complex |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105218585A (en) | A kind of preparation method of genistein chromic compound | |
Li et al. | Syntheses, crystal structures and catalytic activities of two solvent-induced homotrinuclear Co (II) complexes with a naphthalenediol-based bis (Salamo)-type tetraoxime ligand | |
Tamuly et al. | Bio-derived ZnO nanoflower: a highly efficient catalyst for the synthesis of chalcone derivatives | |
Geng et al. | Recognition of silver cations by a cucurbit [8] uril-induced supramolecular crown ether | |
Nunes et al. | New complexes of usnate with lanthanides ions: La (III), Nd (III), Tb (III), Gd (III), synthesis, characterization, and investigation of cytotoxic properties in MCF-7 cells | |
Boghaei et al. | Novel unsymmetrical tetradentate Schiff base complexes of cobalt (II) and palladium (II) with N2O2 donor sets | |
CN106977411A (en) | A kind of synthetic method of N methyltyramines hydrochloride | |
CN110256502A (en) | One kind being based on the complex of ruthenium (II) aromatic hydrocarbons system, preparation method and applications | |
CN109503604A (en) | Benzimidazole benzimidazole derivative and its synthetic method | |
Peewasan et al. | A designed and potentially decadentate ligand for use in lanthanide (iii) catalysed biomass transformations: targeting diastereoselective trans-4, 5-diaminocyclopentenone derivatives | |
Patra et al. | Activation of ortho C–H bond by nickel (II) acetate or sodium tetrachloropalladate (II) in naphthyl imino derivatives of azobenzene | |
CN113248437A (en) | Tetraphenyl vinyl poly-pyrazole nitrogen-containing heterocyclic compound and preparation method and application thereof | |
CN108794553B (en) | Preparation method of baicalin aluminum complex for pig mixed feed | |
CN114805613B (en) | For detecting Fe 3+ Ethyl cellulose base flavonol fluorescent probe and preparation method and application thereof | |
Watakabe et al. | Preparation and properties of molybdenum and tungsten dinitrogen complexes: XX. Reactions of a tungsten-dinitrogen complex with water or alcohols in the presence of ketones. Conversion of ligating dinitrogen into ketazines and isolation of a novel chelate diazo complex as an intermediate | |
CN106892934B (en) | A kind of four polycrystal of 8-hydroxyquinoline metal complex of anion regulation and control and preparation method thereof | |
Kadhum et al. | Synthesis, characterization and biological studies of schiff bases derived from piperonal and their complexes with cobalt (II) | |
Ciobanu et al. | Coordination compounds of Cu (II) with Schiff bases derived from formylmenthone and aromatic amines | |
CN110746465B (en) | Osmium complex, preparation method and application thereof | |
Khan et al. | Preparation, spectral and biological investigation of formaldehyde-based ligand containing piperazine moiety and its various polymer metal complexes | |
Kasumov | Synthesis, spectroscopic and redox properties of nickel (II) salicylaldimine complexes containing sterically hindered phenols | |
Kuimov et al. | Direct phosphorylation of fullerene C 60 with phosphine | |
CN102318833A (en) | Application of glycine as purple corncob anthocyanin pigment assistant agent | |
CN110627838A (en) | Rigid functional ligand-ring metal bridge-functional ligand type iridium complex framework | |
CN112250879B (en) | Method for synthesizing ginkgo leaf polyprenol metal complex with light-operated activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160106 |